カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

月経前症候群(PMS)のグローバル市場2024-2028：鎮痛剤、経口避妊薬・卵巣抑制薬、抗うつ薬、その他

■ 英語タイトル：Global Premenstrual Syndrome Market 2024-2028

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR77208-24）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR77208-24
■ 発行日：2024年1月
■ 調査対象地域：北米、ヨーロッパ、アジア太平洋、その他地域
■ 産業分野：医療
■ ページ数：約120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[月経前症候群(PMS)のグローバル市場2024-2028：鎮痛剤、経口避妊薬・卵巣抑制薬、抗うつ薬、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

月経前症候群(PMS)の世界市場 2024-2028
月経前症候群(PMS)市場は、2023年から2028年にかけて276.72百万米ドルの成長が予測され、予測期間中のCAGRは3.69%で加速すると予測されます。当レポートでは、月経前症候群(PMS)市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、PMSに関する認識や報告の増加、ベンダー間の協力や提携、ハーブや栄養補助食品への嗜好の高まりによって牽引されています。

Technavio社の月経前症候群(PMS)市場は以下のように分類されます：

薬剤クラス別
• 鎮痛薬
• 経口避妊薬および卵巣抑制薬
• 抗うつ薬
• その他

流通チャネル別
• 小売薬局
• 病院薬局
• オンライン薬局

地域別
• 北米
• ヨーロッパ
• アジア
• その他の地域（ROW）

本調査では、今後数年間の月経前症候群(PMS)市場の成長を促進する主な理由の1つとして、遠隔医療の堅調な採用を挙げています。また、地域政府によるPMS治療薬の研究開発および月経健康への取り組みへの高い投資は、市場の大きな需要につながるでしょう。

本レポートでは、月経前症候群(PMS)市場について以下の分野をカバーしています：
• 月経前症候群(PMS)市場のサイジング
• 月経前症候群(PMS)市場の予測
• 月経前症候群(PMS)市場の産業分析

本レポートでは、月経前症候群(PMS)市場の主要ベンダーであるAspen Pharmacare Holdings Ltd、Bayer AG、Bristol Myers Squibb Co.、Eli Lilly and Co.、GlaxoSmithKline Plc、Herbalife International of America Inc.、Hikma Pharmaceuticals Plc、Johnson and Johnson、Lupin Ltd.、Merck KGaA、Novartis AG、Octavius Pharma Pvt. Ltd.、Otsuka Pharmaceutical Co. Ltd.、Pfizer Inc.、Recordati S.p.A、Sanofi SA、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Viatris Inc..などが掲載されています。 また、月経前症候群(PMS)市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場および企業状況プが含まれています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 月経前症候群(PMS)の世界市場：薬効分類別
7 月経前症候群(PMS)の世界市場：流通チャネル別
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global premenstrual syndrome market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global premenstrual syndrome market 2018 – 2022 ($ million)
o 4.2 Drug Class Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Drug Class Segment 2018 – 2022 ($ million)
o 4.3 Distribution Channel Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Drug Class
o 6.1 Market segments
o Exhibit 30: Chart on Drug Class – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Drug Class – Market share 2023-2028 (%)
o 6.2 Comparison by Drug Class
o Exhibit 32: Chart on Comparison by Drug Class
o Exhibit 33: Data Table on Comparison by Drug Class
o 6.3 Analgesics – Market size and forecast 2023-2028
o Exhibit 34: Chart on Analgesics – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Analgesics – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Analgesics – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Analgesics – Year-over-year growth 2023-2028 (%)
o 6.4 Oral contraceptives and ovarian suppression agents – Market size and forecast 2023-2028
o Exhibit 38: Chart on Oral contraceptives and ovarian suppression agents – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Oral contraceptives and ovarian suppression agents – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Oral contraceptives and ovarian suppression agents – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Oral contraceptives and ovarian suppression agents – Year-over-year growth 2023-2028 (%)
o 6.5 Antidepressants – Market size and forecast 2023-2028
o Exhibit 42: Chart on Antidepressants – Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Antidepressants – Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Antidepressants – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Antidepressants – Year-over-year growth 2023-2028 (%)
o 6.6 Others – Market size and forecast 2023-2028
o Exhibit 46: Chart on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 47: Data Table on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 48: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 6.7 Market opportunity by Drug Class
o Exhibit 50: Market opportunity by Drug Class ($ million)
o Exhibit 51: Data Table on Market opportunity by Drug Class ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 52: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 53: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 54: Chart on Comparison by Distribution Channel
o Exhibit 55: Data Table on Comparison by Distribution Channel
o 7.3 Retail pharmacies – Market size and forecast 2023-2028
o Exhibit 56: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o 7.4 Hospital pharmacies – Market size and forecast 2023-2028
o Exhibit 60: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o 7.5 Online pharmacies – Market size and forecast 2023-2028
o Exhibit 64: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 66: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 68: Market opportunity by Distribution Channel ($ million)
o Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 75: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 79: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 91: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 China – Market size and forecast 2023-2028
o Exhibit 99: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.10 UK – Market size and forecast 2023-2028
o Exhibit 103: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.11 Japan – Market size and forecast 2023-2028
o Exhibit 107: Chart on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 108: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
o Exhibit 109: Chart on Japan – Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on Japan – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 119: AbbVie Inc. – Overview
o Exhibit 120: AbbVie Inc. – Product / Service
o Exhibit 121: AbbVie Inc. – Key news
o Exhibit 122: AbbVie Inc. – Key offerings
o 12.4 Bayer AG
o Exhibit 123: Bayer AG – Overview
o Exhibit 124: Bayer AG – Business segments
o Exhibit 125: Bayer AG – Key news
o Exhibit 126: Bayer AG – Key offerings
o Exhibit 127: Bayer AG – Segment focus
o 12.5 Eli Lilly and Co.
o Exhibit 128: Eli Lilly and Co. – Overview
o Exhibit 129: Eli Lilly and Co. – Product / Service
o Exhibit 130: Eli Lilly and Co. – Key news
o Exhibit 131: Eli Lilly and Co. – Key offerings
o 12.6 GlaxoSmithKline Plc
o Exhibit 132: GlaxoSmithKline Plc – Overview
o Exhibit 133: GlaxoSmithKline Plc – Business segments
o Exhibit 134: GlaxoSmithKline Plc – Key news
o Exhibit 135: GlaxoSmithKline Plc – Key offerings
o Exhibit 136: GlaxoSmithKline Plc – Segment focus
o 12.7 Herbalife International of America Inc.
o Exhibit 137: Herbalife International of America Inc. – Overview
o Exhibit 138: Herbalife International of America Inc. – Product / Service
o Exhibit 139: Herbalife International of America Inc. – Key offerings
o 12.8 Johnson and Johnson
o Exhibit 140: Johnson and Johnson – Overview
o Exhibit 141: Johnson and Johnson – Business segments
o Exhibit 142: Johnson and Johnson – Key news
o Exhibit 143: Johnson and Johnson – Key offerings
o Exhibit 144: Johnson and Johnson – Segment focus
o 12.9 Lupin Ltd.
o Exhibit 145: Lupin Ltd. – Overview
o Exhibit 146: Lupin Ltd. – Product / Service
o Exhibit 147: Lupin Ltd. – Key news
o Exhibit 148: Lupin Ltd. – Key offerings
o 12.10 Merck KGaA
o Exhibit 149: Merck KGaA – Overview
o Exhibit 150: Merck KGaA – Business segments
o Exhibit 151: Merck KGaA – Key news
o Exhibit 152: Merck KGaA – Key offerings
o Exhibit 153: Merck KGaA – Segment focus
o 12.11 Novartis AG
o Exhibit 154: Novartis AG – Overview
o Exhibit 155: Novartis AG – Business segments
o Exhibit 156: Novartis AG – Key offerings
o Exhibit 157: Novartis AG – Segment focus
o 12.12 Octavius Pharma Pvt. Ltd.
o Exhibit 158: Octavius Pharma Pvt. Ltd. – Overview
o Exhibit 159: Octavius Pharma Pvt. Ltd. – Product / Service
o Exhibit 160: Octavius Pharma Pvt. Ltd. – Key offerings
o 12.13 Pfizer Inc.
o Exhibit 161: Pfizer Inc. – Overview
o Exhibit 162: Pfizer Inc. – Product / Service
o Exhibit 163: Pfizer Inc. – Key news
o Exhibit 164: Pfizer Inc. – Key offerings
o 12.14 Sanofi SA
o Exhibit 165: Sanofi SA – Overview
o Exhibit 166: Sanofi SA – Business segments
o Exhibit 167: Sanofi SA – Key news
o Exhibit 168: Sanofi SA – Key offerings
o Exhibit 169: Sanofi SA – Segment focus
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 170: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 171: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 172: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 173: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 174: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 175: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 176: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 177: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Viatris Inc.
o Exhibit 178: Viatris Inc. – Overview
o Exhibit 179: Viatris Inc. – Business segments
o Exhibit 180: Viatris Inc. – Key news
o Exhibit 181: Viatris Inc. – Key offerings
o Exhibit 182: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 183: Inclusions checklist
o Exhibit 184: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 185: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 186: Research methodology
o Exhibit 187: Validation techniques employed for market sizing
o Exhibit 188: Information sources
o 13.5 List of abbreviations
o Exhibit 189: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global premenstrual syndrome market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Drug Class Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Drug Class – Market share 2023-2028 (%)
Exhibits31: Data Table on Drug Class – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on Analgesics – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Analgesics – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Analgesics – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Analgesics – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Oral contraceptives and ovarian suppression agents – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Oral contraceptives and ovarian suppression agents – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Oral contraceptives and ovarian suppression agents – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Oral contraceptives and ovarian suppression agents – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Antidepressants – Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Antidepressants – Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Antidepressants – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Antidepressants – Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Others – Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Others – Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Drug Class ($ million)
Exhibits51: Data Table on Market opportunity by Drug Class ($ million)
Exhibits52: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits53: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Distribution Channel
Exhibits55: Data Table on Comparison by Distribution Channel
Exhibits56: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Distribution Channel ($ million)
Exhibits69: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on Japan – Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on Japan – Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Japan – Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AbbVie Inc. – Overview
Exhibits120: AbbVie Inc. – Product / Service
Exhibits121: AbbVie Inc. – Key news
Exhibits122: AbbVie Inc. – Key offerings
Exhibits123: Bayer AG – Overview
Exhibits124: Bayer AG – Business segments
Exhibits125: Bayer AG – Key news
Exhibits126: Bayer AG – Key offerings
Exhibits127: Bayer AG – Segment focus
Exhibits128: Eli Lilly and Co. – Overview
Exhibits129: Eli Lilly and Co. – Product / Service
Exhibits130: Eli Lilly and Co. – Key news
Exhibits131: Eli Lilly and Co. – Key offerings
Exhibits132: GlaxoSmithKline Plc – Overview
Exhibits133: GlaxoSmithKline Plc – Business segments
Exhibits134: GlaxoSmithKline Plc – Key news
Exhibits135: GlaxoSmithKline Plc – Key offerings
Exhibits136: GlaxoSmithKline Plc – Segment focus
Exhibits137: Herbalife International of America Inc. – Overview
Exhibits138: Herbalife International of America Inc. – Product / Service
Exhibits139: Herbalife International of America Inc. – Key offerings
Exhibits140: Johnson and Johnson – Overview
Exhibits141: Johnson and Johnson – Business segments
Exhibits142: Johnson and Johnson – Key news
Exhibits143: Johnson and Johnson – Key offerings
Exhibits144: Johnson and Johnson – Segment focus
Exhibits145: Lupin Ltd. – Overview
Exhibits146: Lupin Ltd. – Product / Service
Exhibits147: Lupin Ltd. – Key news
Exhibits148: Lupin Ltd. – Key offerings
Exhibits149: Merck KGaA – Overview
Exhibits150: Merck KGaA – Business segments
Exhibits151: Merck KGaA – Key news
Exhibits152: Merck KGaA – Key offerings
Exhibits153: Merck KGaA – Segment focus
Exhibits154: Novartis AG – Overview
Exhibits155: Novartis AG – Business segments
Exhibits156: Novartis AG – Key offerings
Exhibits157: Novartis AG – Segment focus
Exhibits158: Octavius Pharma Pvt. Ltd. – Overview
Exhibits159: Octavius Pharma Pvt. Ltd. – Product / Service
Exhibits160: Octavius Pharma Pvt. Ltd. – Key offerings
Exhibits161: Pfizer Inc. – Overview
Exhibits162: Pfizer Inc. – Product / Service
Exhibits163: Pfizer Inc. – Key news
Exhibits164: Pfizer Inc. – Key offerings
Exhibits165: Sanofi SA – Overview
Exhibits166: Sanofi SA – Business segments
Exhibits167: Sanofi SA – Key news
Exhibits168: Sanofi SA – Key offerings
Exhibits169: Sanofi SA – Segment focus
Exhibits170: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits171: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits172: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits173: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits174: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits175: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits176: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits177: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits178: Viatris Inc. – Overview
Exhibits179: Viatris Inc. – Business segments
Exhibits180: Viatris Inc. – Key news
Exhibits181: Viatris Inc. – Key offerings
Exhibits182: Viatris Inc. – Segment focus
Exhibits183: Inclusions checklist
Exhibits184: Exclusions checklist
Exhibits185: Currency conversion rates for US$
Exhibits186: Research methodology
Exhibits187: Validation techniques employed for market sizing
Exhibits188: Information sources
Exhibits189: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 月経前症候群治療のグローバル市場：鎮痛薬、抗うつ薬、経口避妊薬＆卵巣抑制薬、その他
  • イヤーシリンジ（耳用注射器）のグローバル市場2024-2028：バルブ型イヤシリンジ、チューブ型イヤシリンジ
  • 電気生理学(EP)のグローバル市場2024-2028：実験用機器、アブレーションカテーテル、診断用カテーテル、アクセス機器
  • スマートグリッド用遠隔端末装置（RTU）のグローバル市場2024-2028：電力部門、発電所
  • ホームデコ（家庭装飾品）のグローバル市場2024-2028：家具、床材、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR77208-24 )"月経前症候群(PMS)のグローバル市場2024-2028：鎮痛剤、経口避妊薬・卵巣抑制薬、抗うつ薬、その他" (英文：Global Premenstrual Syndrome Market 2024-2028)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。